Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON32501Not yet recruiting
Trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Vrije Universiteit Amsterdam. Primary endpoints: Impact of methylphenidate on reward sensitivity and learning processes, Heart rate response to reward and 1 more. Planned start Sep 2008; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON32501.